CClinicalTrials.gg
Status unknownNCT04255472Updated Feb 25, 2020

Effectiveness of the WHO Caregivers Skills Training Program

An interventional study of WHO Caregiver skills training (CST) program and Treatment as usual in Autism Spectrum Disorder, Development Delay and Developmental Disorder, sponsored by Human Development Research Foundation, Pakistan. Status unknown at 1 site in Pakistan. Open to participants aged 2 Years to 9 Years. Per ClinicalTrials.gov, last updated 2020-02-25.

Sponsored by Human Development Research Foundation, Pakistan · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Feb 2020), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
160
Allocation
Randomized
Ages
2 Years to 9 Years
Sex
All
01

Study summary

Background: Increasing prevalence rates of developmental disorders (DDs) including Autism Spectrum Disorders (ASD) and intellectual disability are a public health priority particularly in Low and Middle Income countries (LIMC) and are included in the World Health Organization (WHO) mhGAP program. However, existing mental health care facilities and resources are insufficient in most low resource settings to cater for this increasing demand. To address this situation, Caregiver Skills Training (CST) program for children with developmental disorders and delays has been developed by the WHO to bridge the treatment gap in low resource settings.

Objective: The objective of this study is to evaluate the effectiveness of the WHO CST program plus treatment as usual (TAU) vs. TAU to improve caregiver-child interaction in children with developmental disorders and delays, when implemented by non-specialist health care facilitators in a low-resource rural community settings of Rawalpindi, Pakistan.

Methods: A two arm, single blind individual randomized controlled trial (RCT) will be carried out with 160 caregiver-child dyads with development disorders and delays in community settings of Rawalpindi, Pakistan. 160 caregiver-child dyads will be individually randomized on 1:1 allocation ratio into intervention (n=80) and control (n=80) arms. Participants in the intervention arm will receive 3-hours group training sessions of WHO CST program once every week for 9 weeks and 3 individual home sessions delivered via non-specialist health care facilitator over a duration of 3-months. The primary outcome is improvement in play-based caregiver-child interaction at 9-months post-intervention. The secondary outcomes are improvement in routine home-based caregiver-child interaction, child's social communication skills, adaptive behavior, emotional and behavioral problems and parental health related quality of life. The data on health services utilization will also be collected at 9-months post-intervention. Qualitative process evaluation with a sub-sample of study participants and trainers will be undertaken following the RCT. The study will be completed within an estimated period of 11-months.

Discussion: Outcomes of the study will be the evidence on the effectiveness of WHO CST program to improve caregiver child interaction and improvement in social communication skills, adaptive behaviors of children with developmental disorders and delays in the low resource setting of Pakistan.

02

Conditions studied

  • Autism Spectrum Disorder
  • Development Delay
  • Developmental Disorder
  • Language Delay
  • Behavioral Problem
  • Emotional Problem
  • Maternal Distress
03

In context

Language Development Disorders

114 studies on the registry are indexed under Language Development Disorders; 47 are open to participants now.

This study's planned enrollment of 160 is above the median of 71 across 100 interventional studies indexed under Language Development Disorders.

Browse Language Development Disorders studies →

Lead sponsor

Human Development Research Foundation, Pakistan is the lead sponsor of 10 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 9 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Children aged 2-9 years old, with developmental disorders and delays as screened by TQS
  • Screened positive on communication problems as identified by Communication and Symbolic Behavior Scale (CSBS) score \<41
  • Developmental Disability-Children's Global Assessment Scale (DD-CGAS) score ≥ 51 as assessed by clinician.

Exclusion criteria

Exclusion Criteria:

  • Children having epilepsy with seizures in the previous 6 months
  • Children with Cerebral Palsy as assessed by the clinician.
  • Co-morbid physical and mental conditions in the child that require inpatient hospitalization.
  • Significant uncorrected hearing and visual impairment in child or parent.
  • Any severe psychiatric or physical illness in primary caregiver requiring inpatient hospitalization.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
160 participants (estimated)

Study arms

  • Experimental
    WHO caregiver skills training program

    Strategies to support children's communication skills by learning to engage in play activities and daily home routines activities with their caregivers.

    Behavioral: WHO Caregiver skills training (CST) program

  • Experimental
    Treatment as usual (TAU)

    TAU in primary healthcare centers for childhood developmental disorders and delays usually consists of no treatment, or a range of alternate treatment regimes, such as multi-vitamin syrups and tablets.

    Behavioral: Treatment as usual

Interventions

  • BehavioralWHO Caregiver skills training (CST) program

    Caregivers are provided with tangible strategies to appropriately respond to their children's emotional regulation, engagement, and communication. Further, the program focuses on helping caregivers to develop their children's communication and adaptive skills while reducing challenging behavior by focusing on identifying the function of the behavior and learning to teach developmentally appropriate replacement skills. The WHO CST program includes nine group sessions delivered at a community venue (e.g., BHU, school, home) and three home visits: the first at entry prior to session 1, the second after session 4, and the third after the final group session. Training for program facilitators will be included prior to the delivery of the intervention.

  • BehavioralTreatment as usual

    WHO CST will be compared with TAU. TAU in primary healthcare centers for childhood developmental disorders and delays usually consists of no treatment, or a range of alternate treatment regimes, such as multi-vitamin syrups and tablets. Evidence-based mental health care is currently not available in primary healthcare centers. A complete record of services availed by the trial participants at tertiary mental healthcare center will be maintained by using an adapted Client Services Receipt Inventory (CSRI) for children with developmental disorders and delays at baseline and end point.

06

What researchers measure

Primary outcomes

  1. Play-based caregiver-child interaction

    The primary outcome will be change in play-based caregiver-child interaction using Joint Engagement Rating Inventory. An observational, video rated tool will be used to rate caregivers-child's engagement and behavior during play and home routine following a communication play protocol on a 7-point Likert scale The tool has been adapted for coding. caregivers' child interaction in the context of Pakistan. Fifteen-minute video taped caregiver-child interaction will be collected at baseline and at endpoint for families in both arms of the study. Caregivers will be asked to try play based routines (e.g. playing with toys or reading a book) with their child or home routines involving the child (e.g. feeding the child performing domestic chores). The videos will be singly coded by trained assessors.

    Time frame: 9-months post-intervention

Secondary outcomes

  1. Adaptive functioning behaviors

    Vineland Adaptive Behavior Scales (VABS) will be used to measure adaptive behaviors. VABS will be used to measure child's functioning in the area of communication, daily living skills, socialization and motor skills. The VABS contains 5 domains each with 2-3 subdomains. The main domains are Communication, Daily Living Skills, Socialization, Motor Skills, and Maladaptive Behavior (optional). There are five general categories of answers for each item. These are "Usually Performs", "Sometimes Perform", "Never Performs", Never had the opportunity to perform" and "Don't know or never observed the child to perform".

    Time frame: At baseline, 9-weeks and 9-months post-intervention follow-up.

  2. Child emotional and behavioral problems

    Child emotional and behavioral problems will be measured through Child Behavior Checklist (CBCL). It consists of 113 questions, scored on a three-point Likert scale (0=absent, 1= occurs sometimes, 2=occurs often). CBCL is made up of eight syndrome scales: anxious/depressed, depressed, somatic complaints, social problems, thought problems, attention problems, rule-breaking behavior, and aggressive behavior.

    Time frame: At baseline, 9-weeks and 9-months post-intervention follow-up.

  3. Parental health related quality of life

    Parental health related quality of life will be measured by Pediatric Quality of Life (PedsQL) Family impact module. It is a 36 items impact module scale that consisting of 6 sub-scales measuring parent self-reported functioning. These subscales measure physical functioning, emotional functioning, social functioning, daily activities and family relationships. Items are rated on a 5-point Likert scale (0 = never to 4= almost always) and add up to 100 score, where higher scores indicate better Health Related Quality of Life.

    Time frame: At baseline, 9-weeks and 9-months post-intervention follow-up.

  4. Health services utilization

    The cost of health services utilization from the time proceeding assessment will be assessed with the adapted Client Services Receipt Inventory (CSRI). It has been adapted to use for the families of children with developmental disorders and delays. It measures the utilization of various health and social care services including time and opportunity losses by the families in the care of their child with developmental disorder and delay.

    Time frame: At baseline and 9-months post-intervention follow-up.

  5. Communication and Symbolic Behavior

    Communication and Symbolic Behavior Scale will be used as a screening tool to identify children with delay in social communication, expressive speech/language, and symbolic functioning, as well as a secondary outcome measures to determine the impact of intervention overtime. CSBS measures 7 language predictors: emotion and eye gaze, communication, gestures, sounds, words, understanding, and object use. CSBS caregiver questionnaire consists of 41 items divided into seven clusters which make three composites i.e. social composite, speech composite and symbolic composite. Items are rated on 3-point Likert scale: "Not Yet/Rarely", "Sometimes" and "Often/Usually".

    Time frame: Screening, 9-weeks & 9-months post-intervention follow-up.

07

Study locations

1 of 1 sites recruiting
  • Human Development Research Foundation
    Islamabad, Pakistan
    Recruiting
08

References and documents

Publications

  • mhGAP Intervention Guide for Mental, Neurological and Substance Use Disorders in Non-Specialized Health Settings: Mental Health Gap Action Programme (mhGAP). Geneva: World Health Organization; 2010. Available from http://www.ncbi.nlm.nih.gov/books/NBK138690/ PubMed 23741783 ↗
  • Chisholm D, Knapp MR, Knudsen HC, Amaddeo F, Gaite L, van Wijngaarden B. Client Socio-Demographic and Service Receipt Inventory--European Version: development of an instrument for international research. EPSILON Study 5. European Psychiatric Services: Inputs Linked to Outcome Domains and Needs. Br J Psychiatry Suppl. 2000;(39):s28-33. doi: 10.1192/bjp.177.39.s28. PubMed 10945075 ↗
  • Wetherby, A.M. and B.M. Prizant, Communication and symbolic behavior scales (CSBS). 2003: Brookes Publishing Company.
  • Sparrow SS, Cicchetti DV. Diagnostic uses of the Vineland Adaptive Behavior Scales. J Pediatr Psychol. 1985 Jun;10(2):215-25. doi: 10.1093/jpepsy/10.2.215. No abstract available. PubMed 4020603 ↗
  • Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999 Feb;37(2):126-39. doi: 10.1097/00005650-199902000-00003. PubMed 10024117 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 25, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04255472
Lead sponsor
Human Development Research Foundation, Pakistan
Collaborators
World Health Organization, University of Liverpool, WHO Collaborating Center for mental health research, Institute of Psychiatry, Rawalpindi, Pakistan
Responsible party
Sponsor
First posted
Feb 5, 2020
Start date
Feb 11, 2020
Primary completion
Dec 31, 2020 (estimated)
Completion
Jan 31, 2021 (estimated)
Last update
Feb 25, 2020

Study contacts

Syed Usman Hamdani, PhD
Contact
usman.hamdani@hdrfoundation.org
0092 512656172
Syed Usman Hamdani, PhD
principal investigator · Human Development Research Foundation, Pakistan

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion